MYX 0.66% $4.60 mayne pharma group limited

Ann: MYX signs license agreement for novel oral contraceptive, page-60

  1. 2,467 Posts.
    lightbulb Created with Sketch. 572
    I hope that all of the positive sentiment holders have expressed is realised for them, but think that an announcement of an agreement to market a product not yet approved, and at a significant capital cost is not without risk.
    2021 before any revenue from this announcement (assuming it gets FDA approval), equals plenty of time for exuberance to subside, and bottom line results be the yardstick against which MYX is measured.

    I am happy to be proved wrong, but I have not been moved to the excitement that the barrackers like Chartsshout have.

    I offloaded today, and think it possible that I may be able to pick them up again down the track for a bit less.
    Obviously, we shall see.

    GLTA
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.